nivolumab
bms
['biomarker', 'nadim', 'nsclc', 'lung', 'lcsm,(-blcsm)', 'nivo', 'sclc']
#nadim-2 path cr &amp; response data #asco22 #lungcancer iiia-b resectable nsclc:nivo +/platinum doublet. clear provocative increased pcr and orr. eagerly awaiting dfs data. with an auroc &gt;0.72, #pdl1 staining for pathcr is a potential biomarker #lcsm #cancer 
Medical Oncologist. MA MD MRCP FRACP @uniofoxford @imperialcollege @rcplondon @theRACP Fellow @ucalgary